Addex Therapeutics's total assets for Q4 2025 were CHF6.37M, a decrease of -25.15% from the previous quarter. ADXN total liabilities were CHF1.60M for the fiscal quarter, a 23.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.